YCT-529, developed by US scientists, moves to early-stage phase 2 trial in New Zealand. Study published in Nature Communications showed it to be 99% effective in preclinical studies.
In 2012, I wrote about the first surrendered Naxal to undergo reverse vasectomy and 'reclaim the right to fatherhood'. Last month, I learnt he still couldn’t bear a child.
IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.
COMMENTS